Lausanne, Switzerland - 3 June 2022. Perfect Holding SA ("Perfect Holding") announced today the completion of the reverse takeover transaction (RTO) with Kinarus AG (“Kinarus”), a clinical-stage biopharmaceutical company engaged in the discovery and development of novel therapeutics for the treatment of viral, respiratory, and ophthalmic diseases.
Perfect Holding acquired Kinarus by way of a share exchange. Kinarus shareholders representing 95.3% of its share capital have tendered their shares in exchange for newly issued shares of Perfect Holding, and such new shares have been admitted for listing and trading on the SIX Swiss Exchange as from 3 June 2022.
In the coming days, Perfect Holding will complete the RTO process with a change of its name to Kinarus Therapeutics Holding AG and a move of its domicile to Basel, Switzerland. The ticker symbol will also be changed from PRFN to KNRS as of 9 June 2022.
The Parties were supported by Raiffeisen Switzerland (listing agent) for this RTO transaction and listing on SIX Swiss Exchange. Kinarus was also supported by Schellenberg Wittmer Ltd (legal counsel) and Ventac Partners (corporate development), while Perfect Holding was assisted by Bär & Karrer (legal counsel). A fairness opinion regarding the terms of the share exchange was provided by The Corporate Finance Group.
